Feasibility and preliminary efficacy of brief tele-psychotherapy for COVID-19 patients and their first-degree relatives.
COVID-19
Telemedicine
Telepsychiatry
Journal
Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
received:
14
12
2022
revised:
01
03
2023
accepted:
11
03
2023
medline:
31
3
2023
pubmed:
20
3
2023
entrez:
19
3
2023
Statut:
ppublish
Résumé
The SARS-CoV-2 pandemic compromised the mental health of COVID-19 patients and their family members. Due to social distancing and lockdown measures, a remote, tele-psychotherapy program for former or current COVID-19 patients and their relatives was implemented. The primary goal of this project was to evaluate intervention feasibility. The secondary aim was to assess the impact of the intervention by means of pre-post psychological changes. After a phone-based eligibility screening and remote neuropsychological testing, participants completed online self-reports assessing baseline COVID-related psychopathology. Next, participants attended eight tele-psychotherapy sessions. After treatment, the online self-reports were completed again. Of 104 enrolled participants, 88 completed the intervention (84.6 % completion rate). Significant pre-post improvements were observed for generalized anxiety (d = 0.38), depression (d = 0.37), insomnia (d = 0.43), post-traumatic psychopathology (d = 0.54), and general malaise (d = 0.31). Baseline cluster analysis revealed a subgroup of 41 subjects (47.6 %) with no psychopathology, and a second subgroup of 45 subject (52.3 %) with moderate severity. Thirty-three percent of the second group reached full symptom remission, while 66 % remained symptomatic after treatment. Remote brief tele-psychotherapy for COVID-19 patients and their first-degree relatives is feasible and preliminary efficacious at reducing COVID-related psychopathology in a subgroup of patients. Further research is needed to investigate distinct profiles of treatment response.
Sections du résumé
BACKGROUND
The SARS-CoV-2 pandemic compromised the mental health of COVID-19 patients and their family members. Due to social distancing and lockdown measures, a remote, tele-psychotherapy program for former or current COVID-19 patients and their relatives was implemented.
OBJECTIVE
The primary goal of this project was to evaluate intervention feasibility. The secondary aim was to assess the impact of the intervention by means of pre-post psychological changes.
METHODS
After a phone-based eligibility screening and remote neuropsychological testing, participants completed online self-reports assessing baseline COVID-related psychopathology. Next, participants attended eight tele-psychotherapy sessions. After treatment, the online self-reports were completed again.
RESULTS
Of 104 enrolled participants, 88 completed the intervention (84.6 % completion rate). Significant pre-post improvements were observed for generalized anxiety (d = 0.38), depression (d = 0.37), insomnia (d = 0.43), post-traumatic psychopathology (d = 0.54), and general malaise (d = 0.31). Baseline cluster analysis revealed a subgroup of 41 subjects (47.6 %) with no psychopathology, and a second subgroup of 45 subject (52.3 %) with moderate severity. Thirty-three percent of the second group reached full symptom remission, while 66 % remained symptomatic after treatment.
CONCLUSIONS
Remote brief tele-psychotherapy for COVID-19 patients and their first-degree relatives is feasible and preliminary efficacious at reducing COVID-related psychopathology in a subgroup of patients. Further research is needed to investigate distinct profiles of treatment response.
Identifiants
pubmed: 36934855
pii: S0165-0327(23)00358-0
doi: 10.1016/j.jad.2023.03.024
pmc: PMC10022466
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
300-308Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest All authors report no conflict of interest.
Références
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
Psychiatry Res. 2021 Jun;300:113916
pubmed: 33836468
Front Psychol. 2021 Dec 02;12:784685
pubmed: 34925187
J Consult Clin Psychol. 2020 Jan;88(1):1-13
pubmed: 31697093
J Affect Disord. 2023 Mar 15;325:682-694
pubmed: 36690081
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
Braz J Psychiatry. 2022 Dec 27;:
pubmed: 36574464
Front Psychiatry. 2020 Oct 30;11:580827
pubmed: 33192723
Philos Trans R Soc Lond B Biol Sci. 2018 Sep 5;373(1754):
pubmed: 30012739
JMIR Res Protoc. 2022 Nov 16;11(11):e39080
pubmed: 36228130
Health Soc Care Community. 2022 Jul;30(4):e1220-e1232
pubmed: 34363273
Curr Probl Cardiol. 2020 Aug;45(8):100618
pubmed: 32439197
QJM. 2020 May 1;113(5):311-312
pubmed: 32227218
Am J Geriatr Psychiatry. 2020 Oct;28(10):1030-1039
pubmed: 32753338
Saudi J Biol Sci. 2016 Jul;23(4):507-11
pubmed: 27298584
Omega (Westport). 2022 Aug;85(3):690-715
pubmed: 32862778
Brain. 2021 Dec 31;144(12):3576-3588
pubmed: 34398188
CNS Drugs. 2022 Jul;36(7):681-702
pubmed: 35727534
Clin Psychol Psychother. 2021 Nov;28(6):1535-1549
pubmed: 33826190
Clin Psychol Psychother. 2022 Nov;29(6):1918-1927
pubmed: 35705786
Sci Rep. 2020 Oct 5;10(1):16476
pubmed: 33020567
Soc Psychiatry Psychiatr Epidemiol. 1990 Sep;25(5):276-80
pubmed: 2237610
Telemed J E Health. 2022 Sep 20;:
pubmed: 36126309
Front Psychol. 2022 Jun 16;13:926520
pubmed: 35783730
Int J Clin Pract. 2021 Mar;75(3):e13746
pubmed: 32991035
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Psychiatry Res. 2022 May;311:114483
pubmed: 35240509
J Pain Symptom Manage. 2020 Dec;60(6):e1-e4
pubmed: 33065207
Eur Arch Psychiatry Clin Neurosci. 2022 Feb;272(1):29-40
pubmed: 33942148
Medsurg Nurs. 2012 Sep-Oct;21(5):321-2
pubmed: 23243796
Front Psychol. 2014 Sep 05;5:979
pubmed: 25249994
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941